GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Ccnd1 | affects expression | ISO | Ccnd1 (Mus musculus) | 6480464 | CTD | Valproic Acid affects the expression of CCND1 mRNA | PMID:17292431 PMID:17963808 | Ccnd1 | decreases expression | ISO | CCND1 (Homo sapiens) | 6480464 | CTD | Valproic Acid results in decreased expression of CCND1 mRNA | PMID:25716160 PMID:29154799 | Ccnd1 | decreases expression | ISO | Ccnd1 (Mus musculus) | 6480464 | CTD | Valproic Acid results in decreased expression of CCND1 mRNA | PMID:21427059 | Ccnd1 | increases expression | ISO | CCND1 (Homo sapiens) | 6480464 | CTD | Valproic Acid results in increased expression of CCND1 mRNA | PMID:19101580 | Ccnd1 | increases methylation | ISO | CCND1 (Homo sapiens) | 6480464 | CTD | Valproic Acid results in increased methylation of CCND1 gene | PMID:28853863 PMID:29201983 | Ccnd1 | multiple interactions | ISO | CCND1 (Homo sapiens) | 6480464 | CTD | [Cisplatin co-treated with Pemetrexed co-treated with Valproic Acid] results in decreased expression of CCND1 protein | PMID:19351772 | |
Go Back to source page | Continue to Ontology report |